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Abstract
 
Platelet-endothelial cell adhesion molecule (PECAM)-1 has been implicated in leukocyte mi-
gration through the perivascular basement membrane (PBM) though the mechanisms involved
are unclear. The present results demonstrate that the ability of 
 
 
 
6
 
 integrins to mediate neutro-
 
phil migration through the PBM is PECAM-1 dependent, a response associated with PECAM-1–
mediated increased expression of 
 
 
 
6
 
 
 
1
 
 on transmigrating neutrophils in vivo. An anti-
 
 
 
6
 
 inte-
grins mAb (GoH3) inhibited (78%, P 
 
  
 
0.001) neutrophil migration through interleukin
(IL)-1
 
 
 
–stimulated cremasteric venules, primarily at the level of the PBM, as analyzed by intra-
vital and electron microscopy. In PECAM-1–deficient mice (KO), a reduced level of neutro-
phil transmigration elicited by IL-1
 
 
 
 (4-h reaction) was observed in both the cremaster muscle
(55% inhibition, P 
 
 
 
 0.05) and in the peritoneum (57% inhibition, P 
 
  
 
0.01) but GoH3 had
no additional inhibitory effect on these responses. FACS
 
®
 
 analysis of neutrophils demonstrated
increased expression of 
 
 
 
6
 
 
 
1
 
 on transmigrated peritoneal neutrophils, as compared with blood
neutrophils, in wild-type but not KO mice even though neutrophils from both strains of mice
exhibited comparable levels of intracellular expression of 
 
 
 
6 
 
as observed by immunofluorescent
staining and confocal microscopy. Furthermore, mice deficient in either leukocyte or endothe-
lial cell PECAM-1, as developed by bone marrow transplantation, demonstrated a similar level
of reduced neutrophil transmigration and expression of 
 
 
 
6
 
 
 
1
 
 on transmigrated neutrophils as
that detected in KO mice.
The results demonstrate a role for PECAM-1 homophilic interaction in neutrophil transmi-
gration and increased expression of 
 
 
 
6
 
 
 
1
 
 on the cell surface of transmigrated neutrophils in
vivo, a response that could contribute to the mechanism of PECAM-1–mediated neutrophil
migration through the PBM.
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Introduction
 
Recruitment of neutrophils into sites of inflammation plays
a central role in the pathogenesis of numerous inflamma-
tory conditions. After the generation of local inflammatory
mediators, the migration of neutrophils from blood to the
extravascular tissue is mediated by a series of sequential
neutrophil–endothelial cell interactions leading to the re-
sponses of neutrophil rolling and firm adhesion within the
vascular lumen, followed by neutrophil migration through
vessel walls. In contrast to our increased understanding of
the cellular and molecular interactions that mediate the
early neutrophil–endothelial cell interactions of rolling and
 
firm adhesion (1), relatively little is known about the mech-
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anisms that mediate penetration of neutrophils through ves-
sel walls. This latter response, termed transmigration, also
involves two distinct sequential cellular events, namely
migration through endothelial cells and migration through
the perivascular basement membrane (PBM).
 
*
 
Although in vitro studies have implicated a number of
adhesion molecules, including the endothelial cell-associ-
ated molecules intercellular adhesion molecule (ICAM)-1,
ICAM-2, platelet-endothelial cell adhesion molecule (PE-
CAM)-1, CD99, and junctional adhesion molecule (JAM;
references 2–4), in migration of leukocytes through endo-
thelial cell junctions, very little is known about the adhe-
sive mechanisms that mediate leukocyte migration through
the PBM. In this context, PECAM-1 is of particular inter-
est since there exists evidence from both in vitro and in
vivo studies to suggest a role for this molecule in leukocyte
migration across both endothelial cells and also through the
PBM (5–9). Although the mechanism by which PECAM-1
mediates migration of leukocytes across endothelial cells
may be explained by the high expression profile of the
molecule at endothelial cell junctions and its ability to me-
diate homophilic binding with PECAM-1 on transmigrat-
ing neutrophils (10), the mechanisms by which PECAM-1
regulates neutrophil migration through the perivascular
basement membrane is unclear.
The first indications for the involvement of PECAM-1
in leukocyte migration through the PBM came from the in
vitro studies of Liao and colleagues demonstrating that an-
tibodies directed against Ig domain 6 of PECAM-1 had no
effect on monocyte transendothelial cell migration but
blocked their subsequent migration into the underlying
collagen gel (5). In vivo, a study from our group demon-
strated that a polyclonal antibody recognizing rat PECAM-1
blocked neutrophil migration through IL-1
 
 
 
–stimulated
rat mesenteric venules at the level of the PBM (9). More
recently, defects in leukocyte migration through the PBM
have been detected in genetically modified mice lacking
PECAM-1 (6, 8). Since to date there have been no reports
on the ability of PECAM-1 to interact with components
of the PBM, the ability of PECAM-1 to mediate leukocyte
migration through this barrier may be related to the signal-
ing properties of the molecule. In this regard, in vitro stud-
ies have shown that antibody cross-linking of PECAM-1
can activate 
 
 
 
1
 
, 
 
 
 
2
 
, and 
 
 
 
3
 
 integrin functions (11–14),
findings that have been extrapolated to suggest that physio-
logical ligation of PECAM-1 may lead to increased expres-
sion of integrins thus aiding the direct interaction of trans-
migrating leukocytes with components of the PBM (e.g.,
laminin and collagen type IV). Despite these in vitro stud-
ies, using protocols that may lead to super-physiological
levels of PECAM-1 engagement, there is to date no in
vivo evidence for the involvement of PECAM-1 in regu-
lation of cell surface expression of integrins on transmigrat-
ing leukocytes, an issue addressed for the first time in the
present study.
As laminin is a key component of all mammalian venular
basement membranes (15), and in the light of the growing
body of in vitro evidence for the potential involvement of
the principal leukocyte laminin receptor 
 
 
 
6
 
 
 
1
 
 in leukocyte
migration through the basement membrane (16–19), the
aim of the present study was to investigate the role and reg-
ulation of expression of 
 
 
 
6
 
 
 
1
 
 during neutrophil transmigra-
tion in vivo. The results demonstrate for the first time a
PECAM-1–dependent role for 
 
 
 
6
 
 integrins in neutrophil
migration through the perivascular basement membrane of
stimulated venules and provide direct in vivo evidence for
a PECAM-1 homophilic interaction leading to both neu-
trophil transmigration and increased expression of 
 
 
 
6
 
 
 
1
 
 on
transmigrating neutrophils. Collectively, the present in
vivo findings provide a potential mechanism for PECAM-
1–mediated migration of neutrophils through the perivas-
cular basement membrane.
 
Materials and Methods
 
Animals.
 
Wild-type C57BL/6 mice (
 
 
 
20 g) were purchased
from Harlan-Olac and PECAM-1–deficient mice, backcrossed
onto the C57BL/6 background for eight generations, were ob-
tained as a gift from Dr. Tak W. Mak (Amgen Institute, Toronto,
Canada).
 
Intravital Microscopy.
 
Intravital microscopy on the mouse cre-
master muscle was performed as described previously (20).
Briefly, male mice were injected intravenously with saline, anti-
 
 
 
6
 
 integrins mAb GoH3 (21) (IgG2a; BD Biosciences), GoH3
F(ab
 
 
 
)
 
2
 
 fragment (all fragmentations were conducted by Cymbus
Biotechnology), anti-
 
 
 
1
 
 integrins mAb HM
 
 
 
1–1 F(ab
 
 
 
)
 
2
 
 (refer-
ence 22; Hamster IgG2; gift from Dr. Hideo Yagita, Juntendo
University, Tokyo, Japan), or an isotype-matched control mAb
(all at 3 mg/kg), 15 min before intrascrotal administration of re-
combinant murine IL-1
 
 
 
 (30 ng). Control groups were injected
with intrascrotal saline (400 
 
 
 
l). 4 h later, the mice were anaes-
thetized by intraperitoneal administration of ketamine (Ketalar;
100 mg/kg; Parke-Davis) and xylazine (Rompun; 10 mg/kg;
Bayer) and placed on a custom-built heated (37
 
 
 
C) microscope
stage where the surgical procedure was performed. Leukocyte–
endothelial cell interactions were observed on a ZEISS Axioskop
fixed-stage upright microscope fitted with water-immersion ob-
jectives. Video recordings were made using a color video camera
and videocassette recorder. Quantifications of rolling flux, adhe-
sion, and transmigration were made as described previously (6).
Briefly, using postcapillary venules of 20–40 
 
 
 
m in diameter,
rolling leukocytes were defined as those moving slower than the
associated blood flow, and rolling flux was quantified as the num-
ber of rolling cells moving past a fixed point on the venular wall
per minute, averaged over 5 min. Firmly adherent cells were
those remaining stationary for 30 s or longer within a given 100-
 
 
 
m segment of venule. Transmigrated leukocytes were those in
the perivenular tissue within 50 
 
 
 
m of the 100-
 
 
 
m vessel seg-
ment under observation. Several vessel segments (range 3–5) from
multiple vessels (range 3–5) were studied for each animal. In
some animals, blood samples were taken by tail-tipping and total
and differential blood leukocyte counts (in blood smears prepared
in a Cytospin-3 cytocentrifuge; Shandon) were determined by
Kimura and May-Grunwald/Giemsa stains, respectively. In se-
 
*
 
Abbreviations used in this paper:
 
 EM, electron microscopy; ICAM, inter-
cellular adhesion molecule; PBM, perivascular basement membrane;
PECAM, platelet-endothelial cell adhesion molecule. 
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lected experiments, erythrocyte centreline velocity was deter-
mined by means of an Optical Doppler Velocimeter (Microcircu-
lation Research Institute) and blood pressure measurements
determined by means of an electronic pressure transducer (Har-
vard Apparatus).
 
Electron Microscopy.
 
At the end of selected experiments, the
cremaster muscle was dissected and prepared for analysis by
transmission electron microscopy (EM) as described previously
(6). Briefly, tissues were fixed in a solution containing glutaralde-
hyde (2.5%), sodium cacodylate (50 mM), hydrochloric acid (4
mM), and calcium chloride (0.18 mM). The samples were then
post-fixed in osmium VIII oxide (1%) and after dehydration in
methanol, were embedded in araldite resin before sectioning.
Ultrathin sections (0.1 
 
 
 
m) of the target area were then mounted
on copper mesh grids and stained with uranyl acetate and lead ci-
trate. The position of migrating leukocytes relative to the endo-
thelium and the perivascular basement membrane was assessed
using a Hitachi 7000 transmission electron microscope (Hitachi
UK), as detailed previously (9). Briefly, for each vessel, the num-
ber of leukocytes in each of the following positions was noted:
A, within lumen of venule; B, crossing endothelium; C, between
endothelium and perivascular basement membrane; D, crossing
basement membrane; E, outside venule, but within 50 
 
 
 
m of it.
For each venule, the fraction of leukocytes that had crossed the
endothelium, but were still inside the basement membrane, was
calculated according to the following equation: C/(C
 
 
 
D
 
 
 
E).
Tissue samples were analyzed from at least four animals and at
least three vessels from each animal studied in detail for each se-
ries of experiments.
 
Quantification of Leukocyte Migration Into the Peritoneal Cavity.
 
Mice were injected intravenously with saline, mAb GoH3
(whole antibody or F(ab
 
 
 
)
 
2
 
 fragment), or control antibody (all at 3
mg/kg), 15 min before the intraperitoneal administration of IL-
1
 
 
 
 (10 ng in 1 ml of saline/cavity). Control mice were injected
with intraperitoneal saline/PBS. 4 h later, the animals were killed
by asphyxiation with CO
 
2
 
, the peritoneal cavity was opened and
lavaged with modified PBS solution (containing 0.25% BSA and
2 mM EDTA). Total and differential count of infiltrating leuko-
cytes was performed as detailed above. Neutrophil infiltration is
expressed as percentage of total infiltrating leukocytes.
 
Flow Cytometry.
 
Whole blood, taken by tail-tipping, and
peritoneal leukocytes, from 4-h exudates after injection of IL-1
 
 
 
(as detailed above), were obtained from the same animals. Blood
samples, diluted 50:50 with anti-coagulant (20 mM EDTA in
PBS), and peritoneal exudates were incubated with primary mAb
on ice and the binding of test mAbs was detected after incubation
with a F(ab
 
 
 
)
 
2
 
 FITC-conjugated goat anti–rat IgG (Serotec Ltd.).
The following rat anti–mouse primary antibodies were used:
GoH3 (IgG2a, anti-
 
 
 
6
 
), 9EG7 (IgG2a, anti-
 
 
 
1
 
), GAME-46
(IgG1, anti-
 
 
 
2
 
), MEL-14 (IgG2a, anti–L-selectin), Mec 13.3
(IgG2a, anti-PECAM-1), and isotype-matched control mAbs
were obtained from BD Biosciences. PS/2 (IgG2b, anti-
 
 
 
4
 
) was
obtained from American Type Culture Collection. After the
addition of FACS
 
®
 
 lysing reagent (Becton Dickinson), samples
were analyzed on an EPICS XL flow cytometer (Beckman
Coulter). Gating on neutrophils was based on characteristic for-
ward and side scatter parameters as well as the binding of mAb
Gr-1 (BD Biosciences). The binding of primary mAbs, relative to
the binding of isotype-matched control mAbs is expressed in
terms of relative fluorescence intensity (RFI).
 
Immunofluorescence Staining and Confocal Analysis of Neutro-
phils.
 
Peripheral blood was collected from WT or PECAM-1–
deficient mice by cardiac puncture and anti-coagulated with 20
mM EDTA. PMN were purified from whole blood as described
previously (6) using a discontinuous Percoll gradient yielding
PMN preparations of 
 
 
 
90% purity. Smears of the freshly isolated
PMN were prepared in a cytocentrifuge (Shandon) and air-dried
overnight. The cells were then fixed with 4% paraformaldehyde
for 15 min followed by permeabilization with 1% Triton X-100
for 30 min, all at room temperature. Nonspecific binding was
blocked with 10% normal rabbit serum for 15 min. The primary
antibody, anti-
 
 
 
6
 
 integrin mAb, GoH3, was incubated with sam-
ples for 1 h, control samples being incubated with PBS only. Af-
ter two washes, the samples were incubated with the secondary
antibody, Alexa Fluor
 
® 
 
633 labeled-goat anti–rat IgG (Molecular
Probes Inc.), at 1:100 at room temperature for 1 h. Finally, the
slides were washed twice in PBS and observed using a ZEISS la-
ser scanning confocal microscope (LSM5 PASCAL), mounted on
a ZEISS Axioskop II FS upright microscope. The 633 nm laser
line was generated from a HeNe laser.
 
Bone Marrow Transplantation.
 
Transfer of bone marrow cells,
as described previously (23), between WT C57BL/6 mice and
PECAM-1–deficient mice was performed to generate mice defi-
cient in either leukocyte or endothelial cell PECAM-1. Briefly,
recipient mice were lethally irradiated with a dose of 9.5Gy for
25 min using a cesium source (IBL 637; Cis Bio International)
24 h before bone marrow transfer. Bone marrow donors were
killed by asphyxiation with CO
 
2
 
 and bone marrow cells were
harvested from both femora under sterile conditions. Each recipi-
ent was injected with 10
 
7
 
 cells by intravenous tail vein injection
and was allowed to generate bone marrow–derived cells for at
least 8 wk before use. The blood leukocyte phenotype of recipi-
ents was determined after 8 wk by indirect immunostaining and
FACS
 
®
 
 analysis as detailed above.
 
Statistics.
 
All results are expressed as mean 
 
 
 
 SEM. Statistical
significance was assessed by means of Mann-Whitney U test or
one way analysis of variance with Neuman-Keuls multiple com-
parison test, as appropriate. P 
 
  
 
0.05 was considered significant.
 
Results
 
An Anti-
 
 
 
6
 
 Integrins mAb, GoH3, Inhibits Neutrophil Mi-
gration through the Perivascular Basement Membrane of IL-1
 
 
 
–
stimulated Mouse Cremasteric Venules.
 
The functional role
of 
 
 
 
6
 
 
 
1
 
 in leukocyte migration through stimulated venules
in vivo was investigated using the anti-
 
 
 
6
 
 integrins mAb
GoH3 (21). For this purpose, the effect of GoH3 was stud-
ied in a model in which we have previously detected
PECAM-1–dependent neutrophil migration through the
PBM (6), namely leukocyte migration through IL-1
 
 
 
–
stimulated mouse cremasteric venules as observed by intra-
vital microscopy. Intrascrotal administration of IL-1
 
 
 
 (30
ng, administered 4 h before quantification of responses) had
no significant effect on leukocyte rolling flux (unpublished
data), but induced a significant increase in leukocyte firm
adhesion and transmigration. In animals treated with mAb
GoH3 (3 mg/kg, intravenously), whole antibody or F(ab
 
 
 
)
 
2
 
fragment, leukocyte transmigration, but not firm adhesion,
was significantly suppressed as compared with mice treated
with an isotype-matched control mAb (78% inhibition,
P 
 
  
 
0.001; Fig. 1). Pretreatment of mice with F(ab
 
 )2 of the
anti- 1 integrin mAb HM 1–1 (3 mg/kg, intravenously)
also suppressed IL-1 –induced transmigration, as compared
with responses obtained in mice treated with a control1204 PECAM-1 Regulates the Expression of  6 1 on Transmigrating Neutrophils
mAb (71% inhibition, P   0.05). None of the reagents
employed had a significant effect on circulating leukocyte
numbers or venular wall shear rates (unpublished data).
The inhibitory effect of GoH3 on leukocyte transmigra-
tion appeared to be at the level of the perivascular base-
ment membrane, as analyzed by transmission. In venular
sections from GoH3-treated animals, but not control-anti-
body treated mice, neutrophils were frequently observed
between the endothelium and the perivascular basement
membrane (Fig. 2, A and B). Quantitative analysis of these
observations indicated that  3 times as many neutrophils
were trapped in IL-1 –stimulated venules of mice treated
with the anti- 6 integrins mAb (whole antibody or F(ab )2
fragment; Fig. 2).
GoH3 Inhibits IL-1 –induced Neutrophil Migration in Wild-
Type but Not PECAM-1–deficient Mice. We next exam-
ined the effect of mAb GoH3 on neutrophil transmigration
in both WT and PECAM-1–deficient mice, using two IL-
1 –driven models, namely neutrophil migration through
IL-1 –stimulated cremasteric venules and neutrophil mi-
gration into IL-1 –stimulated peritoneal cavities. In WT
mice, locally administered IL-1  (intrascrotal 30 ng or in-
traperitoneal 10 ng, administered 4 h before quantification)
elicited significant neutrophil transmigration as compared
with animals injected with saline (Fig. 3). These responses
were almost totally inhibited in mice treated with whole
(Fig. 3) or F(ab )2 fragment of GoH3 (unpublished data).
Interestingly, in PECAM-1–deficient mice, while there
was a significant suppression of IL-1 –induced neutrophil
transmigration in both models (55 and 57% inhibition of
neutrophil transmigration in the cremaster muscle and peri-
toneum, respectively), GoH3 had no additional inhibitory
effects (Fig. 3). With respect to the peritonitis model, we
have used total and differential leukocyte counts to express
the neutrophil migration data as percentage of neutrophil
infiltration due to occasional large variations in total leuko-
cyte numbers. However, as the observed suppressed neu-
trophil migration into IL-1 –stimulated peritoneal cavity
of PECAM-1–deficient mice is a novel and important ob-
servation, the absolute number of total leukocyte counts, as
well as the percent differentials of the infiltrating leuko-
cytes, obtained in response to intraperitoneal PBS or IL-
1 , as compared with thioglycollate, in WT and PECAM-1
KO mice, is shown in Table I. The results demonstrate an
increase in total infiltrating leukocytes and percentage of
neutrophils in response to both IL-1  and thioglycollate in
WT mice. In PECAM-1–deficient mice, no significant dif-
ference in responses elicited by thioglycollate was observed,
as compared with WT mice, in agreement with a previ-
ously published report (8). In contrast, a significant sup-
pression of infiltrating neutrophils was detected after intra-
peritoneal injection of IL-1 , in agreement with the data
presented in Fig. 3. Interestingly, the suppression of neu-
trophil infiltration appeared to be compensated by a signifi-
cant increase in infiltrating mononuclear leukocytes.
Increased Expression of  6 1 on Transmigrated Neutrophils In
Vivo Is PECAM-1 Dependent. As GoH3 inhibited neutro-
phil migration in WT but not PECAM-1–deficient mice,
we investigated the expression of  6 1 on the cell surface of
neutrophils in the two strains of animals. With respect to
blood neutrophils, low levels of cell surface  6 and  1 were
detected in WT and PECAM-1–deficient mice (Fig. 4, A
and B). Similarly, low levels of PECAM-1 (Fig. 4 B) and
 4 integrins (unpublished data) were detected, although
high levels of L-selectin (Fig. 4 B) and  2 integrins were
observed (unpublished data). Overall, no marked differ-
ences in expressions of adhesion molecules were detected
between WT and PECAM-1–deficient blood neutrophils.
With respect to IL-1 –induced peritoneal neutrophils, a
significantly enhanced level of  6 and  1 expression was
detected on cells obtained from WT but not PECAM-1–
deficient mice (Fig. 4, A and B), indicating an association
between cell surface expression of  6 1 on transmigrated
neutrophils and PECAM-1, in vivo. By comparison, cell
surface expression of L-selectin was equally reduced on
transmigrated neutrophils, as compared with blood neutro-
phils, in both WT and KO mice (Fig. 4 B).
Since in human neutrophils  6 1 is reportedly stored
within intracellular granules and up-regulated to the cell
surface after in vitro transendothelial cell migration (24),
one possible explanation for our findings is reduced intra-
Figure 1. Effect of anti- 6 integrins mAb GoH3 on leukocyte migra-
tion through IL-1 –stimulated mouse cremasteric venules, as observed by
intravital microscopy. Animals were treated with intrascrotal saline (white
bars) or IL-1  (30 ng/animal, black bars) 4 h before the surgical prepara-
tion. In additional groups of mice, animals were pretreated with intrave-
nous mAbs GoH3 (anti- 6 integrins), whole antibody or F(ab )2, or an
isotype-matched control mAb, all at the dose of 3 mg/kg, 15 min before
the intrascrotal injection of IL-1 . The panels show leukocyte firm adhe-
sion and transmigration from the same experiments. The data represent
mean   SEM, from n   5–8 mice/group. A significant difference from
responses obtained from saline-injected animals is shown by asterisks,
*P   0.05. Additional statistical comparisons are indicated by lines.1205 Dangerfield et al.
cellular stores of the integrin in PECAM-1 KO neutro-
phils. However, immunofluorescent staining of fixed and
permeabilized mouse neutrophils, as observed by confocal
microscopy, indicated comparable levels of intracellular
 6 expression in neutrophils from both WT and PECAM-
1–deficient mice (Fig. 5). Of interest, stimulation of
mouse blood neutrophils with PMA (100 ng/ml for 20
min) failed to enhance the cell surface expression of  6 1
but as expected significantly elevated the cell surface ex-
pression of  2 and caused the shedding of L-selectin (un-
published data).
Neutrophil Transmigration and Increased Expression of  6 1
on Transmigrated Neutrophils In Vivo Is Mediated by a Ho-
mophilic Interaction between Leukocyte and Endothelial Cell PE-
CAM-1. Having found a role for PECAM-1 in increased
expression of  6 1 on transmigrated neutrophils, we next
sought to determine the relative contributions of leukocyte
and endothelial cell PECAM-1 in this response. For this
purpose, chimeric mice deficient in either endothelial cell
(EC / ) or leukocyte (L / ) PECAM-1, but expressing
WT leukocyte and endothelial cell PECAM-1, respec-
tively, were developed by bone marrow transplantation
(phenotypes were confirmed by FACS® analysis; Fig. 6),
and used in the IL-1  peritonitis model. Interestingly, a
similar suppression of neutrophil transmigration and lack of
Figure 2. Analysis of IL-1 –stimu-
lated cremasteric venules from mice
treated with GoH3, by transmission . A
and B are representative electron micro-
graphs of IL-1  (30 ng/mouse)-stimu-
lated cremasteric venule (4-h test period)
from control antibody-treated or GoH3-
treated mice, respectively. The following
structures are labeled: endothelial cells
(E), neutrophils (N), pericyte (P), and
basement membrane (BM), with a mag-
nification of  5,400. C shows quantified
EM observations as the number of neu-
trophils observed between the venular
endothelium and the perivascular base-
ment membrane, expressed as the per-
centage of the number of neutrophils
that had crossed the venular wall (but
were within 50  m of it), in the tissue
sections analyzed at the 4-h time point.
In all three groups, the antibodies were
administered at the dose of 3 mg/kg in-
travenous 15 min before the intrascrotal
administration of IL-1 . The data repre-
sent mean   SEM from 10–23 randomly
selected vessel segments from 4–7 mice/
group. A significant difference from the
control antibody group is shown by an
asterisk; *P   0.05.
Figure 3. Effect of GoH3 on (A) leukocyte transmigration through
IL-1 –stimulated cremasteric venules and (B) neutrophil infiltration into
IL-1 –stimulated peritoneal cavity of WT and PECAM-1–deficient
mice. Wild-type or PECAM-1–deficient mice were injected with intra-
scrotal (A) or intraperitoneal (B) saline (white bars) or intrascrotal or in-
traperitoneal IL-1  (30 ng/mouse and 10 ng/cavity, respectively), 4 h be-
fore quantification. In the IL-1 –injected groups, the mice were
pretreated with an isotype-matched control antibody or GoH3 (both at 3
mg/kg intravenously) 15 min before administration of IL-1 . The data
represent mean   SEM from n   3–6 mice/group in A and n   5–10 in
B. Significant differences between control IL-1  elicited responses in WT
and PECAM-1–deficient mice are indicated by  P   0.05 and   P  
0.01. Additional statistical comparisons are indicated by lines.1206 PECAM-1 Regulates the Expression of  6 1 on Transmigrating Neutrophils
cell surface expression of  6 on transmigrated neutrophils
was detected using PECAM-1–deficient mice and chimeric
mice lacking either endothelial cell (EC / ) or leukocyte
(L / ) PECAM-1 (Fig. 7), findings that suggest PECAM-1
homophilic interaction mediates both neutrophil transmi-
gration and integrin up-regulation in vivo.
Discussion
The migration of leukocytes through stimulated venular
walls involves their penetration across two distinct barriers,
namely endothelial cells and its associated perivascular base-
ment membrane (PBM). In contrast to our increased un-
derstanding of the molecular and cellular events that medi-
ate leukocyte–endothelial cell interactions, the mechanisms
employed by leukocytes in penetrating the perivascular
basement membrane remain unresolved. An important and
relatively recent development in this field has been the
demonstration that PECAM-1 plays a functional role in
mediating/regulating leukocyte migration through this bar-
rier (5, 6, 8, 9), though the mechanisms by which PE-
CAM-1 may be mediating this response is at present un-
clear. In this regard, the findings of the present study
suggest a PECAM-1–dependent functional role for the
laminin receptor  6 1 in leukocyte migration through the
PBM and for the first time demonstrate a direct in vivo link
Figure 4. Cell surface expression of  6 1, PECAM-1, and L-selectin on blood and IL-1 –elicited peritoneal neutrophils in WT and PECAM-1 defi-
cient (KO) mice. Panel A shows representative fluorescence histograms comparing cell surface expressions of  6 and  1 on blood and IL-1 –induced
peritoneal neutrophils in WT and PECAM-1 deficient mice, as indicated. The filled tracings are from blood samples incubated with an isotype-matched
control mAb (the same low binding was found with peritoneal samples) and the solid and dashed line tracings are from blood and peritoneal samples, re-
spectively, incubated with mAbs GoH3 (anti- 6) or 9EG7 (anti- 1), as indicated. B shows pooled relative fluorescence intensities of samples stained with
specific antibodies and analyzed and quantified by FACS® as detailed in Materials and Methods. The data represent mean   SEM of samples obtained
from n   3–10 animals/group. Significant binding of primary mAbs is indicated by asterisks, *P   0.05, **P   0.01 and other statistical comparisons are
indicated by lines.
Table I. IL-1  and Thioglycollate-induced Leukocyte Migration into the Peritoneum of WT and PECAM-1–deficient (KO) Mice
Stimulus Total leukocytes  Neutrophils Eosinophils
Mononuclear 
leukocytes
( 106)%%%
PBS WT 3.33   0.27 4.15   0.83 1.25   0.48 94.6   0.83
KO 4.46   1.00 3.36   1.81 1.12   0.38 95.5   2.15
IL-  WT 5.03   0.48 24.92   1.92 1.27   0.37 73.86   2.02
(10 ng) KO 5.70   1.04 12.60   2.05** 1.48   0.71 85.93   2.39**
Thioglycollate WT 14.00   1.59 62.18   5.59 0.88   0.34 36.94   5.82
(4%) KO 10.85   1.71 48.63   6.49 0.93   0.21 50.43   6.47
Mice were injected intraperitoneally with PBS (1 ml/cavity), IL-1  (10 ng/cavity), or thioglycollate (1 ml of 4% solution/cavity) 4 h prior to quan-
tification. Total and differential leukocyte counts were determined as detailed in Materials and Methods. The data represent mean   SEM of samples
obtained from n = 4–13 animals/group. Significant differences between samples from WT and KO animals are indicated by **P   0.01.1207 Dangerfield et al.
between PECAM-1 and increased expression of  6 1 on
the cell surface of transmigrating neutrophils. Furthermore,
the data indicate the involvement of a PECAM-1 ho-
mophilic interaction in both neutrophil transmigration and
 6 integrin upregulation in vivo. Collectively the findings
of our study add a new step to the final stage of the cur-
rently accepted multistep paradigm of leukocyte migration
by providing evidence to suggest that the interaction of
neutrophil PECAM-1 with endothelial cell PECAM-1 at
endothelial cell junctions stimulates enhanced expression of
 6 1 on the cell surface of transmigrating neutrophils, thus
aiding their migration through the perivascular basement
membrane via interactions with the laminin component of
this barrier.
The integrin  6 1 was first described on human platelets
(25) but is now known to be expressed by numerous cell
types, including neutrophils (16) and endothelial cells (26).
This molecule is the principal leukocyte receptor for the
basement membrane protein laminin and as such anti- 6 1
antibodies have been shown to block neutrophil adhesion
to the purified protein (16, 18) as well as suppressing neu-
trophil transmigration through endothelial cells cultured on
laminin (19). Such in vitro findings, in conjunction with
the fact that laminin is a major constituent of the basement
membrane (27), have led to suggestions that leukocyte
 6 1 may play a significant role in mediating leukocyte mi-
gration through the PBM though to date there have been
Figure 7. Neutrophil migration and cell surface expression of  6 on
blood and peritoneal neutrophils in an IL-1 –elicited peritonitis model in
WT, PECAM-1–deficient (KO), and chimeric mice deficient in either
leukocyte (L / ) or endothelial cell (E / ) PECAM-1. Mice were in-
jected via the intraperitoneal route with IL-1  (10 ng/animal) and 4 h
later, blood or peritoneal lavage was collected. The lavage fluid was used
to quantify neutrophil infiltration (A). Lavage and blood samples were
also analyzed for the binding of GoH3 (anti- 6) as quantified by FACS®
(B), as detailed in Materials and Methods. The data represent mean  
SEM of samples obtained from n   4–7 animals/group. Significant differ-
ences between peritoneal samples from WT mice and KO, L / , or E / 
mice are indicated by **P   0.01 and ***P   0.001. Other statistical differ-
ences are indicated by lines.
Figure 6. Cell surface expression of PECAM-1 on neutrophils from
chimeric mice having undergone bone marrow transfer. The figure shows
representative fluorescence histograms demonstrating the binding of an
anti-PECAM-1 mAb (Mec 13.3) to blood neutrophils. The filled tracings
are from blood samples incubated with an isotype-matched control mAb
and the solid line tracings are blood samples incubated with Mec 13.3 from
(A) a lethally irradiated WT mouse injected with bone-marrow from a
WT mouse, (B) a lethally irradiated PECAM-1–deficient (KO) mouse in-
jected with bone marrow from a KO mouse, (C) a lethally irradiated KO
mouse injected with bone marrow from a WT mouse, and (D) a lethally
irradiated WT mouse injected with bone marrow from a KO mouse.
Figure 5. Confocal microscopy images of mouse blood neutrophils
immunostained for  6 expression. Cytospins of purified mouse neutro-
phils were prepared, fixed, and permeabilized as detailed in Materials and
Methods. Cell samples were then incubated with or without the primary
antibody, anti- 6 integrin mAb GoH3, and binding was detected using an
Alexa Fluor® 633-labeled secondary Ab before being observed using a
ZEISS confocal microscope. Panel A shows autofluorescence image of
neutrophils (green channel) superimposed on DIC of the same cells. B
shows control cells stained with the secondary Ab in the absence of mAb
GoH3. C and D show positive staining of neutrophils from WT and
PECAM-1–deficient mice, respectively, for  6 integrin. The images are
representative of cells obtained from three different mice/group.1208 PECAM-1 Regulates the Expression of  6 1 on Transmigrating Neutrophils
no in vivo evidence in support of this possibility. In the
first part of the present study the role of  6 1 in neutrophil
migration in vivo was investigated using the anti- 6 inte-
grin mAb GoH3. For this purpose, we employed two IL-
1 –driven inflammatory models, namely leukocyte migra-
tion through IL-1 –stimulated cremasteric venules ( 90%
being neutrophils, as determined by  analysis) and neutro-
phil migration into IL-1 –stimulated peritoneal cavities.
Furthermore, as one of the principal objectives of the study
was to address the potential association of  6 1 with PE-
CAM-1 during neutrophil transmigration, as well as inves-
tigating WT mice, the effect of GoH3 on neutrophil trans-
migration was also investigated in PECAM-1 deficient
animals. Of relevance, although the first paper to report on
the generation and characteristics of PECAM-1–deficient
mice indicated no overall defects in total leukocyte migra-
tion in a number of inflammatory models in these mice, the
study did report a defect in neutrophil migration through
the perivascular basement membrane of mesenteric venules
(8). Using the same mouse strain, in agreement with the
findings of Duncan et al., we observed normal infiltration
of both total leukocytes and neutrophils into the perito-
neum of PECAM-1 KO mice following intraperitoneal ad-
ministration of thioglycollate. However, although in agree-
ment with Duncan et al. we found normal infiltration of
total leukocytes into IL-1 –stimulated peritoneum of
PECAM-1–deficient mice, differential quantification of the
infiltrating leukocytes demonstrated a significant suppres-
sion of neutrophil infiltration. These results are consistent
with our previous observations, demonstrating a stimulus-
specific defect in neutrophil transmigration through cre-
masteric venules of PECAM-1–deficient mice (6). Interest-
ingly, in addition to exhibiting anti-inflammatory profiles,
PECAM-1–deficient mice have recently been reported to
exhibit enhanced proinflammatory responses of increased
vascular permeability and an early onset of EAE (28), add-
ing to the increasing list of phenotypes associated with this
strain of mice.
Pretreatment of control WT mice with mAb GoH3 re-
sulted in a significant blockade of neutrophil transmigration
through IL-1 –stimulated cremasteric venules, as observed
by intravital microscopy, a blockade that appeared to be at
the level of the perivascular basement membrane as ana-
lyzed by transmission EM. GoH3 also blocked neutrophil
infiltration into IL-1 –stimulated peritoneal cavity of WT
mice. Interestingly, however, although in PECAM-1–defi-
cient mice a significant suppression of IL-1 –induced neu-
trophil transmigration was quantified in both models,
GoH3 had no additional inhibitory effects, suggesting that
the functional importance of  6 integrins in neutrophil mi-
gration requires PECAM-1. Hence in PECAM-1 knock-
out mice, the observed neutrophil migration is both inde-
pendent of PECAM-1 and  6 integrins, presumably, as a
result of developmental redundancy, as previously reported
in a number of other cell adhesion molecule deficient mice
(29, 30). For example, neutrophil emigration during endo-
toxin-induced pneumonia was reduced by anti–ICAM-1
mAb or ICAM-1 antisense oligonucleotide, but was not
affected in ICAM-1–deficient mice (31) and anti- v 3–
integrin blockers inhibit angiogenesis in WT mice while
mice deficient in  v or  3 exhibit no defect in angiogenesis
or vasculogenesis (32). Furthermore, by using a direct
quantification procedure, Eppinhimer et al., reported that
compared with WT mice, CD18-, ICAM-1–, and P-selec-
tin–deficient mice exhibit an altered expression of E- and
P-selectin under basal and/or cytokine-stimulated condi-
tions (33). The nature of the compensatory mechanisms
developed in the PECAM-1–deficient mice leading to
PECAM-1- and  6 integrins-independent migration of
neutrophils through the PBM is at present unknown but
will be the subject of future investigations within our labo-
ratory. Hence, as GoH3 had no inhibitory effects on neu-
trophil migration in the PECAM-1–deficient mice, and
in the light of the previous in vitro studies showing that
PECAM-1 ligation can lead to increased expression of
integrins, including  1 integrins (11), we hypothesized that
the dependency of neutrophil migration on  6 1 and
PECAM-1 may be functionally associated. To investigate
this possibility, we next examined the cell surface expres-
sion of  6 1 on blood and transmigrated neutrophils in
both WT and PECAM-1–deficient animals.
Blood neutrophils from WT and PECAM-1 KO mice
exhibited similar profiles of expression of selected adhesion
molecules, as quantified by flow cytometric analysis, a tech-
nique that also confirmed the absence of leukocyte PECAM-1
in the latter. Specifically, neutrophils from the two strains
of mice showed comparable and significant levels of L-selec-
tin and  2 integrins, but low levels of  6 or  1 were de-
tected. The low expression of  6 1 on blood neutrophils
detected in the present study is in agreement with previous
reports (21, 34, 35). In contrast to blood neutrophils, IL-
1 –elicited peritoneal neutrophils exhibited a significantly
enhanced level of  6 1 in WT mice, a response that was
not detected in PECAM-1–deficient animals. Increased ex-
pression of  6 and/or  1 on transmigrated human neutro-
phils in vitro (24, 36) and increased expression of  1 inte-
grins on transmigrated human and rat neutrophils in vivo
(34, 37), have previously been demonstrated, results that
are in agreement with our findings. However, using a clean
model of genetic deletion, the present study extends these
observations by providing evidence for a direct association
between PECAM-1 and increased expression of  6 1. Of
importance, since in human neutrophils there is indirect
evidence for expression of  6 1 within intracellular gran-
ules, a store that is up-regulated to the cell surface after in
vitro transendothelial cell migration (24), one possible ex-
planation for the low level of  6 1 on the cell surface of
transmigrated neutrophils in the PECAM-1–deficient mice
is an overall lower level of intracellular stores of the inte-
grin in PECAM-1–deficient neutrophils. However, direct
analysis of  6 expression in permeabilized mouse blood
neutrophils immunostained by GoH3 and analyzed by con-
focal microscopy indicated comparable levels of intracel-
lular  6 integrins in neutrophils obtained from WT and
PECAM-1–deficient mice. Of interest, in agreement with
a previous report (18), stimulation of mouse neutrophils1209 Dangerfield et al.
with PMA did not lead to increased cell surface expression
of  6, suggesting that regulation of expression of  6 1 is
mediated through adhesive events, as discussed below.
Having demonstrated a functional role for PECAM-1 in
increased expression of  6 1 on the cell surface of transmi-
grated neutrophils in vivo, in a final series of experiments
we sought to investigate the relative roles of neutrophil and
endothelial cell PECAM-1 in this response. For this pur-
pose, chimeric mice deficient in either leukocyte or endo-
thelial cell PECAM-1 were generated by bone marrow
transfer between PECAM-1–deficient and WT animals.
Using these mice in the IL-1 –elicited peritonitis model, a
similar suppression of neutrophil migration was detected in
mice deficient in either leukocyte or endothelial cell PECAM-1
as that detected in the KO mice. Furthermore, the results
demonstrated that increased expression of  6 on transmi-
grating neutrophils required both leukocyte and endothe-
lial cell PECAM-1. Collectively the present results provide
the first direct evidence for a homophilic PECAM-1–
PECAM-1 interaction mediating integrin up-regulation in
vivo. Hence, in conjunction with previous observations,
the present results suggest that while PECAM-1–PECAM-1
interaction at endothelial cell junctions supports leukocyte
migration through endothelial cell junctions, through its
ability to stimulate increased expression of  6 1, this in-
teraction also mediates leukocyte migration through the
PBM. At first glance this conclusion may appear in conflict
with the in vitro observations of Liao et al. (5) demonstrat-
ing that while homophilic PECAM-1 interactions (via do-
main 1 and 2) support monocyte migration across endo-
thelial cells, heterophilic PECAM-1 interactions (via its
domain 6) support monocyte migration through basement
membrane like collagen gels. However, it is possible that in
the study of Liao and colleagues, blockade of homophilic
PECAM-1–PECAM-1 interactions by mAbs directed
against domains 1 and/or 2 as well as inhibiting the migra-
tion of monocytes across endothelial cells may also have
blocked integrin upregulation, though the latter was not
quantified and would not have been easily evident within
the experimental protocol used. The mechanism by which
blockade of domain 6 (believed to support heterophilic
PECAM-1 interactions) inhibited monocyte migration
through collagen gels is still unclear though this possible
discrepancy between our results and those of Liao et al.
may involve different PECAM-1–dependent mechanisms
employed by different leukocyte subtypes, e.g. monocytes
as compared with neutrophils (investigated in this study)
and/or differences between the species or models investi-
gated. Furthermore, although in vitro studies have demon-
strated or suggested that PECAM-1 can support both ho-
motypic and heterotypic interactions (10), to our knowledge
there is no evidence for the occurrence of the latter in vivo.
Indeed, previous in vivo investigations support our findings
by providing evidence to suggest the involvement of
PECAM-1 homophilic interaction in neutrophil migration
in vivo (38–40).
The mechanism by which neutrophil PECAM-1 liga-
tion mediates increased expression of  6 1 is at present un-
clear but may involve translocation of the integrin from
granules, as has been suggested from in vitro studies using
human neutrophils (24). To our knowledge however, a
correlation between leukocyte PECAM-1 ligation and leu-
kocyte degranulation has not been reported but is currently
under investigation in our laboratory. Furthermore, with
respect to  6 1, very little is known about the physiological
mechanisms that regulate the expression/activation of this
integrin on leukocytes (18, 41). In this context, the present
in vivo findings strongly suggest transmigration as an im-
portant regulator of  6 1 expression, and perhaps activa-
tion, a response that may determine the efficiency with
which the leukocytes subsequently interact with compo-
nents of the perivascular basement membrane and/or ex-
travascular tissue. Of relevance, transmigration has previ-
ously been shown to be an effective regulator of expression
of other  1 integrins such as  4 1 (36) and  2 1 (34). The
stimulatory effect of transmigration and the apparent lack of
effect of soluble neutrophil chemoattractants or PMA on
expression of  1 integrins (18, 34, 37) suggest the require-
ment of adhesion-mediated signaling events in the regula-
tion of expression of these family of integrins, as has been
demonstrated by Werr and colleagues (42) and indicated in
the present study.
In summary, we have demonstrated a functional role for
 6 integrins in neutrophil migration through the perivascu-
lar basement membrane, a response that appears to be
PECAM-1 dependent. Furthermore, the study provides di-
rect in vivo evidence for the involvement of a homophilic
interaction between leukocyte and endothelial cell PECAM-1
in neutrophil transmigration and enhanced expression of
 6 1 on transmigrated neutrophils, collectively suggesting a
role for PECAM-1 homophilic interaction in both neutro-
phil migration through endothelial cell junctions and
through the perivascular basement membrane. Indeed, lack
of defects in leukocyte transendothelial cell migration but
defects in leukocyte migration through the PBM in PECAM-
1–deficient animals (6, 8) suggests a key role for PECAM-1
in regulation of leukocyte migration through the latter bar-
rier. However, even in this regard, there is evidence for
PECAM-1–independent mechanisms as the observed de-
fect in leukocyte migration through the PBM in PECAM-
1–deficient mice is transient and stimulus specific (6) and
the lack of inhibitory effect of  6 integrin blockade in the
PECAM-1 KO mice indicates the existence of PECAM-1–
and  6 1-independent mechanisms of leukocyte transmi-
gration. Future characterization of such mechanisms will en-
hance our understanding of the molecular events involved
in leukocyte emigration as well as identifying targets for
the development of novel antiinflammatory therapies.
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